Skip to main content
OpenTrials

Clinical trial condition

Geographic Atrophy

Explore clinical trials studying Geographic Atrophy. Study availability and eligibility vary by location and protocol.

134 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Geographic Atrophy trial results

Completed

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

NCT02463344

Conditions
Age-Related Macular Degeneration, Eye Diseases, Geographic Atrophy, +3 more
Locations
  • Jules Stein Eye Institute, UCLA School of Medicine Los Angeles, California, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
  • Mass Eye and Ear Boston, Massachusetts, United States
  • Wills Eye Institute-Mid Atlantic Retina Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration

NCT01344993

Conditions
Dry Age Related Macular Degeneration, Eye Diseases, Geographic Atrophy, +3 more
Locations
  • Jules Stein Eye Institute, UCLA School of Medicine Los Angeles, California, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
  • Mass Eye and Ear Boston, Massachusetts, United States
  • Wills Eye Institute-Mid Atlantic Retina Philadelphia, Pennsylvania, United States
View Trial Details
Completed

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

NCT04597632

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +16 more
Locations
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Fort Lauderdale, Florida, United States
  • Novartis Investigative Site Indianapolis, Indiana, United States
  • Novartis Investigative Site Minneapolis, Minnesota, United States
View all 60 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

NCT04005352

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +17 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Loma Linda, California, United States
  • Novartis Investigative Site Riverside, California, United States
View all 118 locations
View Trial Details
Completed

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy

NCT04656561

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Site 5 Phoenix, Arizona, United States
  • Site 31 Bakersfield, California, United States
  • Site 2 Beverly Hills, California, United States
  • Site 19 Mountain View, California, United States
View all 53 locations
View Trial Details
Completed

Geographic Atrophy Long-Terms Outcomes Study

NCT06499571

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Sydney West Retina Westmead, New South Wales, Australia
  • Centre Hospitalier de la Croix Rousse Lyon, Rhone, France
  • Universitaetsklinikum Muenster Münster, North Rhine-Westphalia, Germany
  • Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco) Milan, Italy
View Trial Details
Completed

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

NCT03927690

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +22 more
Locations
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Rancho Cordova, California, United States
  • Novartis Investigative Site Miami, Florida, United States
  • Novartis Investigative Site ‘Aiea, Hawaii, United States
View all 22 locations
View Trial Details
Completed

A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

NCT03525613

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Arizona Retina & Vitreous Consultants Phoenix, Arizona, United States
  • California Retina Consultants Bakersfield, California, United States
  • Retina Vitreous Associates Medical Group Beverly Hills, California, United States
  • Retinal Diagnostic Center Campbell, California, United States
View all 112 locations
View Trial Details
Completed

Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

NCT03525600

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Retinal Research Institute Phoenix, Arizona, United States
  • Associated Retina Consultants, Ltd Phoenix, Arizona, United States
  • Retina Institute of California dba Acuity Eye Grp Arcadia, California, United States
  • California Retina Consultants Bakersfield, California, United States
View all 141 locations
View Trial Details
Completed

Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD

NCT02684578

Conditions
Age-Related Macular Degeneration, Dry Macular Degeneration, Eye Diseases, +5 more
Locations
  • University of California, Davis Davis, California, United States
  • Palo Alto Veteran Affairs Medical Center Palo Alto, California, United States
  • Retinal Consultants Medical Group Sacramento, California, United States
  • San Francisco Veteran Affairs Medical Center San Francisco, California, United States
View Trial Details

Related conditions